Stay updated on Abemaciclib Combinations in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Abemaciclib Combinations in Pancreatic Cancer Clinical Trial page.

Latest updates to the Abemaciclib Combinations in Pancreatic Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
- Check43 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
- Check50 days agoChange DetectedA new study on Abemaciclib (LY2835219) for treating previously treated pancreatic ductal adenocarcinoma has been added, along with helpful links from Eli Lilly and Company.SummaryDifference0.7%
- Check57 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check65 days agoChange DetectedThe website has been updated to version v2.14.0, adding a new type of intervention while removing the previous version's type of intervention and a study related to Abemaciclib.SummaryDifference0.8%
Stay in the know with updates to Abemaciclib Combinations in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abemaciclib Combinations in Pancreatic Cancer Clinical Trial page.